{"id": "article-19231_0", "title": "Cervical Dysplasia -- Continuing Education Activity", "content": "The Pap smear is responsible for decreasing the incidence of and mortality rates from cervical cancer. The Papanicolaou (Pap) smear is a collection of cells from the squamocolumnar junction of the cervix where the columnar epithelium is juxtaposed to the smooth squamous epithelium. In this area, squamous metaplasia is causing squamous cells to replace columnar cells. This cell growth and change can allow the entrance of human papillomavirus (HPV), the cause of more than 90% of cervical cancer. The Pap smear is a sample of cells from this area to screen a patient for abnormalities such as cervical dysplasia. This activity reviews the etiology, presentation, evaluation, and management of cervical dysplasia and reviews the role of the interprofessional team in evaluating, diagnosing, and managing the condition.", "contents": "Cervical Dysplasia -- Continuing Education Activity. The Pap smear is responsible for decreasing the incidence of and mortality rates from cervical cancer. The Papanicolaou (Pap) smear is a collection of cells from the squamocolumnar junction of the cervix where the columnar epithelium is juxtaposed to the smooth squamous epithelium. In this area, squamous metaplasia is causing squamous cells to replace columnar cells. This cell growth and change can allow the entrance of human papillomavirus (HPV), the cause of more than 90% of cervical cancer. The Pap smear is a sample of cells from this area to screen a patient for abnormalities such as cervical dysplasia. This activity reviews the etiology, presentation, evaluation, and management of cervical dysplasia and reviews the role of the interprofessional team in evaluating, diagnosing, and managing the condition."}
{"id": "article-19231_1", "title": "Cervical Dysplasia -- Continuing Education Activity", "content": "Objectives: Review the pathophysiology of cervical dysplasia, starting with its precursors and progressing through to its most serious sequelae. Describe the history, examination, and evaluation procedures for patients with suspected cervical dysplasia. Summarize the appropriate treatment approach to cervical dysplasia based on degree. Outline interprofessional team strategies for improving care coordination and communication to improve outcomes with cervical dysplasia. Access free multiple choice questions on this topic.", "contents": "Cervical Dysplasia -- Continuing Education Activity. Objectives: Review the pathophysiology of cervical dysplasia, starting with its precursors and progressing through to its most serious sequelae. Describe the history, examination, and evaluation procedures for patients with suspected cervical dysplasia. Summarize the appropriate treatment approach to cervical dysplasia based on degree. Outline interprofessional team strategies for improving care coordination and communication to improve outcomes with cervical dysplasia. Access free multiple choice questions on this topic."}
{"id": "article-19231_2", "title": "Cervical Dysplasia -- Introduction", "content": "The pap smear is responsible for decreasing the incidence of and mortality rates from cervical cancer. The Papanicolaou (Pap) smear is a collection of cells from the squamocolumnar junction of the cervix where the columnar epithelium is juxtaposed to the smooth squamous epithelium. In this area, squamous metaplasia is causing squamous cells to replace columnar cells. This cell growth and change can allow the entrance of human papillomavirus (HPV), the cause of more than 90% of cervical cancer. The Pap smear is a sample of cells from this area to screen a patient for abnormalities such as cervical dysplasia. [1] [2] [3] [4]", "contents": "Cervical Dysplasia -- Introduction. The pap smear is responsible for decreasing the incidence of and mortality rates from cervical cancer. The Papanicolaou (Pap) smear is a collection of cells from the squamocolumnar junction of the cervix where the columnar epithelium is juxtaposed to the smooth squamous epithelium. In this area, squamous metaplasia is causing squamous cells to replace columnar cells. This cell growth and change can allow the entrance of human papillomavirus (HPV), the cause of more than 90% of cervical cancer. The Pap smear is a sample of cells from this area to screen a patient for abnormalities such as cervical dysplasia. [1] [2] [3] [4]"}
{"id": "article-19231_3", "title": "Cervical Dysplasia -- Etiology", "content": "Cervical dysplasia is the precursor to cervical cancer. It is caused by the persistent infection of the human papillomavirus (HPV) into the cervical tissue. The most common type is HPV 16, responsible for 50% of cervical cancer. HPV 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68 are the other HPV oncogenic types. HPV is a common, sexually transmitted infection that usually clears within eight to 24 months of exposure. Persistent infection leads to dysplasia, which, if untreated, can lead to cervical cancer. The process is usually slow and occurs over several years. Because of the slow\u00a0progression\u00a0of this identifiable and treatable infection, it is amenable to routine screening with a Pap smear and/or HPV testing depending on the patient's age and history. [5] [6] [7]", "contents": "Cervical Dysplasia -- Etiology. Cervical dysplasia is the precursor to cervical cancer. It is caused by the persistent infection of the human papillomavirus (HPV) into the cervical tissue. The most common type is HPV 16, responsible for 50% of cervical cancer. HPV 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68 are the other HPV oncogenic types. HPV is a common, sexually transmitted infection that usually clears within eight to 24 months of exposure. Persistent infection leads to dysplasia, which, if untreated, can lead to cervical cancer. The process is usually slow and occurs over several years. Because of the slow\u00a0progression\u00a0of this identifiable and treatable infection, it is amenable to routine screening with a Pap smear and/or HPV testing depending on the patient's age and history. [5] [6] [7]"}
{"id": "article-19231_4", "title": "Cervical Dysplasia -- Epidemiology", "content": "The HPV virus is transmitted through skin to skin contact, most commonly through sexual contact. Nonsexual transfer can occur with fomites, but the transmission typically\u00a0is\u00a0seen with genital contact and sexual activity. Multiple sexual partners or a partner who has multiple sexual partners significantly increases the risk of exposure. Exposure at a young age also increases the risk of persistent HPV. This is based on the observation that HPV infection is most common in young women 18-30 years old, with prevalence sharply declining after age 30. The greatest metaplastic activity of the cervix is during puberty and the first pregnancy; HPV needs to infect these areas to have the DNA incorporated into the cell. The median age of HPV-associated cervical cancer diagnosis is 49. This implies an earlier age of exposure because it has a slow growing dysplastic process, which leads to cancer\u00a0in approximately 10-30\u00a0years.", "contents": "Cervical Dysplasia -- Epidemiology. The HPV virus is transmitted through skin to skin contact, most commonly through sexual contact. Nonsexual transfer can occur with fomites, but the transmission typically\u00a0is\u00a0seen with genital contact and sexual activity. Multiple sexual partners or a partner who has multiple sexual partners significantly increases the risk of exposure. Exposure at a young age also increases the risk of persistent HPV. This is based on the observation that HPV infection is most common in young women 18-30 years old, with prevalence sharply declining after age 30. The greatest metaplastic activity of the cervix is during puberty and the first pregnancy; HPV needs to infect these areas to have the DNA incorporated into the cell. The median age of HPV-associated cervical cancer diagnosis is 49. This implies an earlier age of exposure because it has a slow growing dysplastic process, which leads to cancer\u00a0in approximately 10-30\u00a0years."}
{"id": "article-19231_5", "title": "Cervical Dysplasia -- Pathophysiology", "content": "HPV infects the basal cells of the squamous epithelium of the cervix. Once inside the host cell, the HPV DNA replicates as the basal cells differentiate and progress to the surface of the epithelium. The HPV gene expression becomes unlinked to the state of cellular differentiation of infected epithelial cells, and deregulation expression of the early region of the viral genome results in a\u00a0dramatic increase in the expression of the two HPV oncoproteins (E6 and E7). This results in the loss of the normal cell cycle control of the epithelium, and cells will develop morphologic features with immature \"basaloid- type\" squamous cells and mitotic figures in the upper half of the cervical epithelium. These features can be seen\u00a0on colposcopy when acetic acid is applied to the cervix. A biopsy of this area is performed and sent to the pathologist to evaluate the degree of dysplasia present.", "contents": "Cervical Dysplasia -- Pathophysiology. HPV infects the basal cells of the squamous epithelium of the cervix. Once inside the host cell, the HPV DNA replicates as the basal cells differentiate and progress to the surface of the epithelium. The HPV gene expression becomes unlinked to the state of cellular differentiation of infected epithelial cells, and deregulation expression of the early region of the viral genome results in a\u00a0dramatic increase in the expression of the two HPV oncoproteins (E6 and E7). This results in the loss of the normal cell cycle control of the epithelium, and cells will develop morphologic features with immature \"basaloid- type\" squamous cells and mitotic figures in the upper half of the cervical epithelium. These features can be seen\u00a0on colposcopy when acetic acid is applied to the cervix. A biopsy of this area is performed and sent to the pathologist to evaluate the degree of dysplasia present."}
{"id": "article-19231_6", "title": "Cervical Dysplasia -- History and Physical", "content": "The link of papillomaviruses\u00a0to squamous cancers\u00a0was first discovered\u00a0in\u00a0the 1930s\u00a0by the research\u00a0of Dr. Richard Shope. By the 1950s and 1960s, a potential link between viral infections and cervical cancer was noted. In 1984,\u00a0Harald zur Hausen discovered, cloned, and attributed cervical cancer to HPV 16 and 18; he would later win a Nobel Prize for his work. Over the next 15 years, scientists worked to link cervical cancer and HPV, showing\u00a0that HPV is the trigger for cervical cancer.", "contents": "Cervical Dysplasia -- History and Physical. The link of papillomaviruses\u00a0to squamous cancers\u00a0was first discovered\u00a0in\u00a0the 1930s\u00a0by the research\u00a0of Dr. Richard Shope. By the 1950s and 1960s, a potential link between viral infections and cervical cancer was noted. In 1984,\u00a0Harald zur Hausen discovered, cloned, and attributed cervical cancer to HPV 16 and 18; he would later win a Nobel Prize for his work. Over the next 15 years, scientists worked to link cervical cancer and HPV, showing\u00a0that HPV is the trigger for cervical cancer."}
{"id": "article-19231_7", "title": "Cervical Dysplasia -- Evaluation", "content": "The most common way to identify cervical dysplasia starts with a Pap smear. Most Pap smears are now liquid-based cytology that will identify normal and abnormal cellularity. Molecular testing for the high-risk HPV subtypes types can be performed from the liquid samples if indicated. The Pap smear is a\u00a0screening test, and based on the abnormality of the screening test, the next step in evaluation may be colposcopy. During this procedure, the cervix is examined with a microscope, and 5% acetic acid is applied to the cervix to identify\u00a0abnormal areas. The dysplastic areas will turn an aceto-white color. Sometimes Lugol solution may be utilized if one is unable to see\u00a0abnormalities with acetic acid; this will result in a non-staining area. A biopsy of any abnormal areas is sent to the pathologist who identifies any evidence of cervical dysplasia. [8] [9] [10] [11]", "contents": "Cervical Dysplasia -- Evaluation. The most common way to identify cervical dysplasia starts with a Pap smear. Most Pap smears are now liquid-based cytology that will identify normal and abnormal cellularity. Molecular testing for the high-risk HPV subtypes types can be performed from the liquid samples if indicated. The Pap smear is a\u00a0screening test, and based on the abnormality of the screening test, the next step in evaluation may be colposcopy. During this procedure, the cervix is examined with a microscope, and 5% acetic acid is applied to the cervix to identify\u00a0abnormal areas. The dysplastic areas will turn an aceto-white color. Sometimes Lugol solution may be utilized if one is unable to see\u00a0abnormalities with acetic acid; this will result in a non-staining area. A biopsy of any abnormal areas is sent to the pathologist who identifies any evidence of cervical dysplasia. [8] [9] [10] [11]"}
{"id": "article-19231_8", "title": "Cervical Dysplasia -- Treatment / Management", "content": "There are different degrees of dysplasia. Based on the \u00a0Lower Anogenital Squamous Terminology (LAST)\u00a0project, pathologists should call the specimen low-grade squamous intraepithelial lesion (LSIL) or high-grade squamous intraepithelial lesion (HSIL). LSIL, classically referred to as CIN1 or mild dysplasia, does not require treatment and should be followed conservatively. Patients with LSIL should return in one\u00a0year for co-testing. This involves a repeat Pap smear with HPV molecular testing as the majority of the lesions will regress on their own. HSIL, classically referred to as CIN2/3 or CIS, usually requires an excisional procedure for treatment. Ablative procedures can be offered, but the majority of clinicians perform excisional procedures to give the pathologist a better specimen to evaluate. Excisional procedures provide\u00a0assurance that an underlying cancer is identified, and adequate treatment for the lesion is provided. A \u00a0loop electrosurgical excision procedure (LEEP)\u00a0to remove the abnormal tissue with a thin electrified wire that cuts the specimen from the cervix\u00a0can be performed in the office. A cold knife cone (CKC) typically\u00a0is performed in the operating room,\u00a0using a knife to resect a cone-shaped\u00a0portion of cervical tissue. The advantage of a CKC\u00a0is that the pathologist can identify the margins more clearly\u00a0and because they are not obscured by\u00a0the burn artifact created with the electrified wire. Following a complete excision and negative margins, patients require yearly follow-up\u00a0with a pap smear.\u00a0 If underlying cancer is discovered, treatment plans are expanded, and an oncologist is consulted. If an excisional procedure provides results in positive LEEP margin findings,\u00a0the decision to re-excise or\u00a0follow conservatively is\u00a0based on the patient\u2019s age and fertility status. [12] [13] [14]", "contents": "Cervical Dysplasia -- Treatment / Management. There are different degrees of dysplasia. Based on the \u00a0Lower Anogenital Squamous Terminology (LAST)\u00a0project, pathologists should call the specimen low-grade squamous intraepithelial lesion (LSIL) or high-grade squamous intraepithelial lesion (HSIL). LSIL, classically referred to as CIN1 or mild dysplasia, does not require treatment and should be followed conservatively. Patients with LSIL should return in one\u00a0year for co-testing. This involves a repeat Pap smear with HPV molecular testing as the majority of the lesions will regress on their own. HSIL, classically referred to as CIN2/3 or CIS, usually requires an excisional procedure for treatment. Ablative procedures can be offered, but the majority of clinicians perform excisional procedures to give the pathologist a better specimen to evaluate. Excisional procedures provide\u00a0assurance that an underlying cancer is identified, and adequate treatment for the lesion is provided. A \u00a0loop electrosurgical excision procedure (LEEP)\u00a0to remove the abnormal tissue with a thin electrified wire that cuts the specimen from the cervix\u00a0can be performed in the office. A cold knife cone (CKC) typically\u00a0is performed in the operating room,\u00a0using a knife to resect a cone-shaped\u00a0portion of cervical tissue. The advantage of a CKC\u00a0is that the pathologist can identify the margins more clearly\u00a0and because they are not obscured by\u00a0the burn artifact created with the electrified wire. Following a complete excision and negative margins, patients require yearly follow-up\u00a0with a pap smear.\u00a0 If underlying cancer is discovered, treatment plans are expanded, and an oncologist is consulted. If an excisional procedure provides results in positive LEEP margin findings,\u00a0the decision to re-excise or\u00a0follow conservatively is\u00a0based on the patient\u2019s age and fertility status. [12] [13] [14]"}
{"id": "article-19231_9", "title": "Cervical Dysplasia -- Differential Diagnosis", "content": "Cervicitis Endometrial carcinoma Pelvic inflammatory disease Vaginitis", "contents": "Cervical Dysplasia -- Differential Diagnosis. Cervicitis Endometrial carcinoma Pelvic inflammatory disease Vaginitis"}
{"id": "article-19231_10", "title": "Cervical Dysplasia -- Pearls and Other Issues", "content": "A hysterectomy is not the standard of care to treat cervical dysplasia. However, the finding\u00a0of recurrent cervical dysplasia may be treated with hysterectomy. Post hysterectomy\u00a0patients will not\u00a0develop cervical cancer as the cervix has been removed,\u00a0but\u00a0must still receive Pap smears of the remaining vaginal cuff for\u00a020 years due to the risk of vaginal dysplasia and subsequent cancer. Vaginal cancer is extremely rare, with fewer than 5,000 cases a year, but individuals with a history of severe cervical dysplasia are at the greatest risk for this disease.\u00a0Patients undergoing a hysterectomy for benign indications without a history significant for a high-grade cervical dysplasia no longer need cytological screening or HPV screening as her risk of vaginal cancer is very low. The three vaccines developed to prevent HPV infection are one which provides protection from HPV 16 and 18, another which covers 6, 11, 16 and 18, and most recently released, a 9-valent vaccine which protects from HPV 6, 11, 16, 18, 31, 33, 45, 52 and 58.\u00a0Even though 6 and 11 are not oncogenic subtypes of HPV, they are responsible for genital warts, which are problematic to the patient and can be passed along to an infant during pregnancy. Genital warts are a\u00a0significant source of medical\u00a0spending in the US. Once the Gardasil 4 vaccines\u00a0are depleted,\u00a0the only vaccine to be manufactured in the United States will be Gardasil 9. This vaccine is indicated in girls and boys ages nine to 26, preferably before any sexual contact or exposure, to prevent cervical, vaginal, and vulvar cancers as well as penile, anal, and certain types of head and neck cancers. This is a virus-like particle vaccine which cannot reproduce in the human body and is considered safe by the\u00a0Food and Drug Administration\u00a0(FDA) and\u00a0 Centers for Disease Control and Prevention (CDC).", "contents": "Cervical Dysplasia -- Pearls and Other Issues. A hysterectomy is not the standard of care to treat cervical dysplasia. However, the finding\u00a0of recurrent cervical dysplasia may be treated with hysterectomy. Post hysterectomy\u00a0patients will not\u00a0develop cervical cancer as the cervix has been removed,\u00a0but\u00a0must still receive Pap smears of the remaining vaginal cuff for\u00a020 years due to the risk of vaginal dysplasia and subsequent cancer. Vaginal cancer is extremely rare, with fewer than 5,000 cases a year, but individuals with a history of severe cervical dysplasia are at the greatest risk for this disease.\u00a0Patients undergoing a hysterectomy for benign indications without a history significant for a high-grade cervical dysplasia no longer need cytological screening or HPV screening as her risk of vaginal cancer is very low. The three vaccines developed to prevent HPV infection are one which provides protection from HPV 16 and 18, another which covers 6, 11, 16 and 18, and most recently released, a 9-valent vaccine which protects from HPV 6, 11, 16, 18, 31, 33, 45, 52 and 58.\u00a0Even though 6 and 11 are not oncogenic subtypes of HPV, they are responsible for genital warts, which are problematic to the patient and can be passed along to an infant during pregnancy. Genital warts are a\u00a0significant source of medical\u00a0spending in the US. Once the Gardasil 4 vaccines\u00a0are depleted,\u00a0the only vaccine to be manufactured in the United States will be Gardasil 9. This vaccine is indicated in girls and boys ages nine to 26, preferably before any sexual contact or exposure, to prevent cervical, vaginal, and vulvar cancers as well as penile, anal, and certain types of head and neck cancers. This is a virus-like particle vaccine which cannot reproduce in the human body and is considered safe by the\u00a0Food and Drug Administration\u00a0(FDA) and\u00a0 Centers for Disease Control and Prevention (CDC)."}
{"id": "article-19231_11", "title": "Cervical Dysplasia -- Enhancing Healthcare Team Outcomes", "content": "The screening and management of cervical HPV infection are best managed by an interprofessional team that includes the nurse practitioner, primary care provider, pathologist, and gynecologist.\u00a0There are different degrees of dysplasia. Based on the \u00a0Lower Anogenital Squamous Terminology (LAST)\u00a0project, pathologists should call the specimen low-grade squamous intraepithelial lesion (LSIL) or high-grade squamous intraepithelial lesion (HSIL). LSIL, classically referred to as CIN1 or mild dysplasia, does not require treatment and should be followed conservatively. Patients with LSIL should return in one\u00a0year for co-testing. This involves a repeat Pap smear with HPV molecular testing as the majority of the lesions will regress on their own. HSIL, classically referred to as CIN2/3 or CIS, usually requires an excisional procedure for treatment. Ablative procedures can be offered, but the majority of clinicians perform excisional procedures to give the pathologist a better specimen to evaluate. Excisional procedures provide\u00a0assurance that an underlying cancer is identified, and adequate treatment for the lesion is provided. The key is for the healthcare provider to\u00a0recommend positive lifestyle changes and get vaccinated against HPV. \u00a0Pharmacists often administer the vaccine and counsel patients as to the risks and benefits. Ambulatory care and pediatric nurses also administer vaccines and make sure patients follow up. [12] [13] [14]", "contents": "Cervical Dysplasia -- Enhancing Healthcare Team Outcomes. The screening and management of cervical HPV infection are best managed by an interprofessional team that includes the nurse practitioner, primary care provider, pathologist, and gynecologist.\u00a0There are different degrees of dysplasia. Based on the \u00a0Lower Anogenital Squamous Terminology (LAST)\u00a0project, pathologists should call the specimen low-grade squamous intraepithelial lesion (LSIL) or high-grade squamous intraepithelial lesion (HSIL). LSIL, classically referred to as CIN1 or mild dysplasia, does not require treatment and should be followed conservatively. Patients with LSIL should return in one\u00a0year for co-testing. This involves a repeat Pap smear with HPV molecular testing as the majority of the lesions will regress on their own. HSIL, classically referred to as CIN2/3 or CIS, usually requires an excisional procedure for treatment. Ablative procedures can be offered, but the majority of clinicians perform excisional procedures to give the pathologist a better specimen to evaluate. Excisional procedures provide\u00a0assurance that an underlying cancer is identified, and adequate treatment for the lesion is provided. The key is for the healthcare provider to\u00a0recommend positive lifestyle changes and get vaccinated against HPV. \u00a0Pharmacists often administer the vaccine and counsel patients as to the risks and benefits. Ambulatory care and pediatric nurses also administer vaccines and make sure patients follow up. [12] [13] [14]"}
{"id": "article-19231_12", "title": "Cervical Dysplasia -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Cervical Dysplasia -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}